ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University balticbusinessnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from balticbusinessnews.com Daily Mail and Mail on Sunday newspapers.
Japan s Ono Pharmaceutical
Co said on Tuesday its $2.4 billion takeover of
Deciphera Pharmaceuticals is a first step in
expanding in U.S. and European markets. WHY IT S.
By Rocky Swift TOKYO (Reuters) - Japan's Ono Pharmaceutical Co said on Tuesday its $2.4 billion takeover of Deciphera Pharmaceuticals is a "first step" in expanding in U.S. and European markets. WHY IT'S IMPORTANT With this deal, Ono Pharma joins J.
Deciphera Shareholders to Receive $25.60 per Share in Cash
Deciphera’s Kinase Inhibitor Expertise and Established Commercialization Platform in Key Markets Will Reinforce ONO Pharmaceutical’s.
Ono Pharmaceutical will pay $25.60 per Deciphera share in cash, a premium of nearly 75 percent on the Waltham cancer biotech’s closing price of $14.65 on Friday.